Clinical research sites for the niaaa medications development clinical investigations network for the treatment of alcohol use disorder

Active Awarded Last action

Contract number
75N94021D00003
Awardee
Awarding agency
Task orders
1 $118,843 obligated

Award facts

Combined order value
$118,843 Current and potential, with all options
Last date to order 80% complete
IDV ceiling <1% used
$48,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
National Institute on Alcohol Abuse and Alcoholism National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute on Alcohol Abuse and Alcoholism awarded a single-award IDIQ to Boston Medical Center Corporation on March 15, 2021, with a ceiling of $48 million for clinical research sites supporting the NIAAA Medications Development Clinical Investigations Network for the treatment of alcohol use disorder, with ultimate completion on March 14, 2028.

Place of performance is Roxbury, Massachusetts. The originating solicitation sought multiple IDIQs for clinical research sites to conduct Phase I and Phase II clinical trials for medications development to treat alcohol use disorder, including recruitment and enrollment of human subjects, Good Clinical Practice testing, data collection and reporting, and collaboration with the existing contract research organization. The pre-solicitation notice anticipated approximately ten contract awards with a seven-year ordering period; anticipated recruitment targets were 35–40 subjects per site per trial, supporting testing of one compound every 1.5–2 years over seven years, with individual trial periods of 1.5–2 years each. NAICS code 541715 and PSC R410 apply.

Period of performance spans the base through options to March 14, 2028. A delivery order issued on March 15, 2021, carries a ceiling of $118,843.09 for core function activities, advisory services, and administrative reporting on a cost-no-fee basis, with completion on March 14, 2025, and place of performance in Roxbury, Massachusetts.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 · EO14398 clinical research sites for the niaaa medications development clinical investigations network for the treatment of alcohol use disorder $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N94021D00003?

75N94021D00003 was awarded to Boston Medical Center Corporation by National Institute of Child Health and Human Development (National Institutes of Health) on March 15, 2021.

How much is contract 75N94021D00003 worth?

Orders under 75N94021D00003 have obligated $118,843. 75N94021D00003's own ceiling is $48,000,000.

How many orders have been placed under contract 75N94021D00003?

1 order has been placed under 75N94021D00003, the latest on March 15, 2021.

Which agency awarded contract 75N94021D00003?

National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94021D00003, with funding from National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health).

Who can order from contract 75N94021D00003?

75N94021D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N94021D00003 part of a contract vehicle?

Yes. 75N94021D00003 is part of Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder.

Was contract 75N94021D00003 competed?

The extent of competition for 75N94021D00003 was full and open competition. The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV